Tumor Infiltrating Lymphocytes Therapy
Summary
The European Patent Office published patent application EP4329782A1 for Alethia Biotherapeutics ULC covering tumor infiltrating lymphocytes (TIL) therapy for cancer treatment. The application includes 17 IPC classifications including cell compositions, antibodies, and combination therapies. The patent designates 35 European states including Germany, France, UK, Italy, Spain, and the Netherlands.
What changed
The European Patent Office published EP4329782A1, a patent application for tumor infiltrating lymphocytes (TIL) therapy filed by Alethia Biotherapeutics ULC. The application covers therapeutic compositions and methods for treating cancer using infiltrating lymphocytes, including combination therapies with antibodies and chemotherapy agents.
Affected parties including pharmaceutical companies, biotech firms, and researchers developing cell-based cancer immunotherapies should monitor this patent for potential licensing implications or freedom-to-operate considerations in European markets.
Archived snapshot
Apr 19, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
TUMOR INFILTRATING LYMPHOCYTES THERAPY
Publication EP4329782A1 Kind: A1 Apr 08, 2026
Applicants
Alethia Biotherapeutics ULC
Inventors
FILION, Mario
IPC Classifications
A61K 35/17 20150101AFI20250402BHEP A61K 31/337 20060101ALI20250402BHEP A61K 39/395 20060101ALI20250402BHEP A61P 35/00 20060101ALI20250402BHEP A61P 35/04 20060101ALI20250402BHEP C07D 305/14 20060101ALI20250402BHEP C07K 16/18 20060101ALI20250402BHEP C12N 5/078 20100101ALI20250402BHEP A61K 39/00 20060101ALI20250402BHEP A61K 31/704 20060101ALI20250402BHEP A61K 40/11 20250101ALI20250402BHEP A61K 40/42 20250101ALI20250402BHEP C12N 5/0781 20100101ALI20250402BHEP C12N 5/0783 20100101ALI20250402BHEP A61K 45/06 20060101ALI20250402BHEP C07K 16/30 20060101ALI20250402BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.